Theratechnologies Provides Update on Trogarzo (Ibalizumab-Uiyk) Injection Prescriptions and Reimbursement Status Pharmaceutical Investing
Insmed Announces FDA Acceptance for Filing of New Drug Application for ALIS in NTM Lung Disease Caused by MAC Pharmaceutical Investing
Xenon Presents XEN901 Phase 1 Clinical Update and Supporting Pre-clinical Data at 14th Eilat Conference Pharmaceutical Investing
PreveCeutical Medical: Second Shipment of Dried Cannabis Materials Arrives at the Pharmacy Australia Centre of Excellence Biotech Investing
Zymeworks and Daiichi Sankyo Expand Immuno-Oncology Collaboration Focused on Bispecific Antibodies Pharmaceutical Investing
Galectin Therapeutics Proceeds to Phase 3 Development of GR-MD-02 for NASH Cirrhosis Following FDA Meeting Pharmaceutical Investing
